Entrada Therapeutics
About the Company
Entrada Therapeutics is a clinical‑stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Our Endosomal Escape Vehicle (EEV™)-therapeutics enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada advances a robust development portfolio of RNA‑and protein‑based programs for the potential treatment of neuromuscular and ocular diseases, among others.
Our lead oligonucleotide programs target Duchenne Muscular Dystrophy exon 44, 45, 50 and 51 skipping amenable patients and we have a clinical‑stage program, VX‑670, for myotonic dystrophy type 1. We are a tight‑knit team of experts and leaders in therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high‑energy, dedicated team that likes to get things done and dramatically improve the lives of patients and families.
The Perfect Addition to Our Team Join a high‑growth organization where your expertise directly shapes how scientific data is communicated internally and externally. Thrive in a collaborative and fast‑paced environment that requires strategic thinking, strong project management, and attention to detail. Learn the science behind Entrada’s platforms and pipeline and translate complex data into clear, accurate, and compelling scientific materials.
The Opportunity The Director, Scientific Communications Lead will report directly into the Senior Vice President of Medical Affairs and will play an integral role in supporting Entrada’s portfolio in the neuromuscular and ocular space. The leader will guide the creation and execution of the medical affairs publication and scientific communications strategy. They will also develop the scientific communications plan, which includes the scientific platform, the medical education plan, the evidence generation plan, and the publications and congress plan.
As an internal medical affairs resource, this leader will bring or develop subject‑matter expertise in neuromuscular and ocular diseases and will work closely with internal partners to ensure scientific accuracy and consistency. They will oversee the design and delivery of internal and external training programs that strengthen understanding across key teams.
Responsibilities
Ensure the development and execution of publication, congress, training, scientific communication and medical education strategy across multiple platforms (conventional, digital, congress).
Conduct literature reviews and gap analyses to identify data needs, inform strategy, and guide development of scientific communication tactics.
Ensure creation of high quality, scientifically accurate, and compliant deliverables including slide decks, disease state materials, manuscript summaries, program specific FAQs, congress summaries, advisory board materials, training materials and other internal and external resources.
Develop program specific scientific materials such as mechanism of disease or action graphics, data summary decks, and templates for company wide use.
Provide writing and editorial support for abstracts, posters, manuscripts, and other publications, including conducting literature searches and preparing annotated summaries for internal teams.
Oversee congress activities including content development for Discovery/Research and Medical Affairs presence, abstract coverage, congress summaries, and all related deliverables in collaboration with Corporate Communications, Investor Relations, and Competitive Intelligence.
Lead publication planning activities including cross‑functional coordination, management of review and approval processes for external and field based materials, tracking of company or investigator‑led publications, and ensuring adherence to publication and scientific exchange compliance requirements including GPP3, ICMJE, and Sunshine Act guidance.
Provide project management support for Scientific Communications including maintenance of slide libraries and repositories, version control, process design and improvement, and implementation of innovative approaches such as digital tools and publication metrics tracking.
Lead medical and scientific messaging for medical affairs and ensuring these messages are aligned across all forms of scientific, field and corporate messaging.
Partner with and manage vendor(s) to lead the execution of the scientific communications plan overseeing medical writing agencies including project initiation, execution, and closing; working with authors on submissions to congresses, journals etc, managing revisions, and budget.
Collaborate with cross‑functional teams/colleagues to develop evidence generation, publication and congress activities to ensure insight sharing and alignment across teams, and efficient execution of strategies and tactics.
Support market access efforts by developing appropriate medical materials and supportive documents and by providing medical expertise as required to internal and external stakeholders.
The Necessities (Values)
Humanity
– We genuinely care about patients and about one another.
Tenacity
– We are relentless and persistent in the pursuit of developing therapies for patients.
Creativity
– We are creative problem solvers.
Collaboration
– We are more than the sum of our parts.
Curiosity
– We have a growth mindset and push conventional thought and theory.
Qualifications
Must have an advanced medical degree (MD, DO, or equivalent), PharmD or PhD.
Experience in rare diseases, launch experience, and vendor management experience are advantages.
8+ years of medical affairs experience in the Pharmaceutical/Biotechnology industry.
Experience in neuromuscular disease and Duchenne’s Muscular Dystrophy a plus.
Proven success in a fast‑paced, entrepreneurial, smaller company environment is highly desired.
Proven experience in working collaboratively and cross‑functionally across the enterprise field medical teams, corporate affairs, clinical development, commercial, sales, market access and other key functions and demonstrated ability to inform and shape company/product strategy.
Demonstrated understanding of laws, regulations, standards, and guidance governing the conduct of publications.
Understanding of relevant GCP, ICH and FDA/EMA regulations.
Ability to travel approximately 20% of the time both domestically and internationally, as determined by business needs.
This role follows a hybrid working model, with office attendance 2–3 days per week minimum at the Entrada Therapeutics Headquarters in Boston, MA.
What We Offer At Entrada Therapeutics, we understand that compensation and total rewards are a major consideration when exploring a new opportunity. We believe in transparency and equity and are committed to sharing salary ranges for every position, along with insight into our compensation philosophy. In addition to competitive salaries, employees receive comprehensive health, dental and vision coverage; life and disability insurance; a 401(k) match; paid, gender‑inclusive parental leave; holistic support for health and well‑being; education reimbursement; discretionary time off; and commuting benefits aligned to a hybrid working model.
Salary range for this position: $225,000–$253,000. Final base compensation will depend on qualifications and experience.
Equal Opportunity Employer Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.
Privacy Statement Entrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and you can learn how we collect, use, share, or otherwise process your personal information by reviewing our privacy statement here.
#J-18808-Ljbffr
Our lead oligonucleotide programs target Duchenne Muscular Dystrophy exon 44, 45, 50 and 51 skipping amenable patients and we have a clinical‑stage program, VX‑670, for myotonic dystrophy type 1. We are a tight‑knit team of experts and leaders in therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high‑energy, dedicated team that likes to get things done and dramatically improve the lives of patients and families.
The Perfect Addition to Our Team Join a high‑growth organization where your expertise directly shapes how scientific data is communicated internally and externally. Thrive in a collaborative and fast‑paced environment that requires strategic thinking, strong project management, and attention to detail. Learn the science behind Entrada’s platforms and pipeline and translate complex data into clear, accurate, and compelling scientific materials.
The Opportunity The Director, Scientific Communications Lead will report directly into the Senior Vice President of Medical Affairs and will play an integral role in supporting Entrada’s portfolio in the neuromuscular and ocular space. The leader will guide the creation and execution of the medical affairs publication and scientific communications strategy. They will also develop the scientific communications plan, which includes the scientific platform, the medical education plan, the evidence generation plan, and the publications and congress plan.
As an internal medical affairs resource, this leader will bring or develop subject‑matter expertise in neuromuscular and ocular diseases and will work closely with internal partners to ensure scientific accuracy and consistency. They will oversee the design and delivery of internal and external training programs that strengthen understanding across key teams.
Responsibilities
Ensure the development and execution of publication, congress, training, scientific communication and medical education strategy across multiple platforms (conventional, digital, congress).
Conduct literature reviews and gap analyses to identify data needs, inform strategy, and guide development of scientific communication tactics.
Ensure creation of high quality, scientifically accurate, and compliant deliverables including slide decks, disease state materials, manuscript summaries, program specific FAQs, congress summaries, advisory board materials, training materials and other internal and external resources.
Develop program specific scientific materials such as mechanism of disease or action graphics, data summary decks, and templates for company wide use.
Provide writing and editorial support for abstracts, posters, manuscripts, and other publications, including conducting literature searches and preparing annotated summaries for internal teams.
Oversee congress activities including content development for Discovery/Research and Medical Affairs presence, abstract coverage, congress summaries, and all related deliverables in collaboration with Corporate Communications, Investor Relations, and Competitive Intelligence.
Lead publication planning activities including cross‑functional coordination, management of review and approval processes for external and field based materials, tracking of company or investigator‑led publications, and ensuring adherence to publication and scientific exchange compliance requirements including GPP3, ICMJE, and Sunshine Act guidance.
Provide project management support for Scientific Communications including maintenance of slide libraries and repositories, version control, process design and improvement, and implementation of innovative approaches such as digital tools and publication metrics tracking.
Lead medical and scientific messaging for medical affairs and ensuring these messages are aligned across all forms of scientific, field and corporate messaging.
Partner with and manage vendor(s) to lead the execution of the scientific communications plan overseeing medical writing agencies including project initiation, execution, and closing; working with authors on submissions to congresses, journals etc, managing revisions, and budget.
Collaborate with cross‑functional teams/colleagues to develop evidence generation, publication and congress activities to ensure insight sharing and alignment across teams, and efficient execution of strategies and tactics.
Support market access efforts by developing appropriate medical materials and supportive documents and by providing medical expertise as required to internal and external stakeholders.
The Necessities (Values)
Humanity
– We genuinely care about patients and about one another.
Tenacity
– We are relentless and persistent in the pursuit of developing therapies for patients.
Creativity
– We are creative problem solvers.
Collaboration
– We are more than the sum of our parts.
Curiosity
– We have a growth mindset and push conventional thought and theory.
Qualifications
Must have an advanced medical degree (MD, DO, or equivalent), PharmD or PhD.
Experience in rare diseases, launch experience, and vendor management experience are advantages.
8+ years of medical affairs experience in the Pharmaceutical/Biotechnology industry.
Experience in neuromuscular disease and Duchenne’s Muscular Dystrophy a plus.
Proven success in a fast‑paced, entrepreneurial, smaller company environment is highly desired.
Proven experience in working collaboratively and cross‑functionally across the enterprise field medical teams, corporate affairs, clinical development, commercial, sales, market access and other key functions and demonstrated ability to inform and shape company/product strategy.
Demonstrated understanding of laws, regulations, standards, and guidance governing the conduct of publications.
Understanding of relevant GCP, ICH and FDA/EMA regulations.
Ability to travel approximately 20% of the time both domestically and internationally, as determined by business needs.
This role follows a hybrid working model, with office attendance 2–3 days per week minimum at the Entrada Therapeutics Headquarters in Boston, MA.
What We Offer At Entrada Therapeutics, we understand that compensation and total rewards are a major consideration when exploring a new opportunity. We believe in transparency and equity and are committed to sharing salary ranges for every position, along with insight into our compensation philosophy. In addition to competitive salaries, employees receive comprehensive health, dental and vision coverage; life and disability insurance; a 401(k) match; paid, gender‑inclusive parental leave; holistic support for health and well‑being; education reimbursement; discretionary time off; and commuting benefits aligned to a hybrid working model.
Salary range for this position: $225,000–$253,000. Final base compensation will depend on qualifications and experience.
Equal Opportunity Employer Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.
Privacy Statement Entrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and you can learn how we collect, use, share, or otherwise process your personal information by reviewing our privacy statement here.
#J-18808-Ljbffr